Silibinin-loaded magnetic nanoparticles inhibit hTERT gene expression and proliferation of lung cancer cells

References

• Akbarzadeh A, Badrzadeh F, Zarghami N, Yamchi MR, Zeighamian V, Tabatabae FS, et al. 2014. Comparison between effects of free curcumin and curcumin loaded NIPAAm-MAA nanoparticles on telomerase and PinX1 gene expression in lung cancer cells. Asian Pac J Cancer Prev. 15:8931–8936.
   PubMedGoogle Scholar
• Alibakhshi A, Ranjbari J, Pilehvar-Soltanahmadi Y, Nasiri M, Mollazade M, Zarghami N. 2016. An update on phytochemicals substances in molecular target therapy of cancer: potential inhibitory effect on telomerase activity. Curr Med Chem. 23:2380–2393.
   PubMed Web of Science ®Google Scholar
• Ardebili MO, Amoabediny G, Rezayat S, Akbarzadeh A, Ebrahimi B. 2015. Design and preparation of encapsulated nano-liposome controlled release including silibinin anti-cancer herbal drug (nano phytosome). SSU_J. 23:2000–2012.
   Google Scholar
• Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Karydas A, Ithakissios D. 2002. PLGA–mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J Control Release. 79:1:123–135.
   PubMed Web of Science ®Google Scholar
• Beletsi A, Panagi Z, Avgoustakis K. 2005. Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymers. Int J Pharm. 298:233–241.
   PubMed Web of Science ®Google Scholar
• Bodnar A, Lichtsteiner S, Kim N, Trager J. 1997. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet. 17:502–498.
   Web of Science ®Google Scholar
• Cao SW, Zhu YJ, Ma MY, Li L, Zhang L. 2008. Hierarchically nanostructured magnetic hollow spheres of Fe3O4 and γ-Fe2O3: preparation and potential application in drug delivery. J Phys Chem C 112:1851–1856.
   Web of Science ®Google Scholar
• Deep G, Agarwal R. 2010. Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer. Cancer Metastasis Rev. 29:47–63.
   Web of Science ®Google Scholar
• Dobson J. 2006. Magnetic nanoparticles for drug delivery. Drug Develop Res. 67:55–60.
   Web of Science ®Google Scholar
• Dube D, Khatri K, Goyal AK, Mishra N, Vyas SP. 2010. Preparation and evaluation of galactosylated vesicular carrier for hepatic targeting of silibinin. Drug Develop Ind Pharm. 36:547–555.
   PubMed Web of Science ®Google Scholar
• Ebrahimnezhad Z, Zarghami N, Keyhani M, Amirsaadat M, Akbarzadeh A, Rahmati M, et al. 2013. Inhibition of hTERT gene expression by silibinin-loaded PLGA-PEG-Fe3O4 in T47D breast cancer cell line. Bioimpacts. 3:67–74.
   PubMedGoogle Scholar
• Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. 2015. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–EE86.
   PubMed Web of Science ®Google Scholar
• Kazemi-Lomedasht F, Rami A, Zarghami N. 2013. Comparison of inhibitory effect of curcumin nanoparticles and free curcumin in human telomerase reverse transcriptase gene expression in breast cancer. Adv Pharm Bull. 3:127–130.
   PubMedGoogle Scholar
• Kedar E, Palgi O, Golod G, Babai I, Barenholz Y. 1997. Delivery of cytokines by liposomes. III. Liposome-encapsulated GM-CSF and TNF-[alpha] show improved pharmacokinetics and biological activity and reduced toxicity in mice. J Immunother. 20:180–181.
   PubMed Web of Science ®Google Scholar
• Kim NW, Piatyszek MA, Prowse KR, Harley CB. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:2011.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Inose H, Nakagawa T, Kubota Y, Gonda K, Ohuchi N. 2013. X-ray imaging technique using colloid solution of Au/silica core-shell nanoparticles. J Nanostruct Chem. 3:1–6.
   Google Scholar
• Li J, Li B, Xu WW, Chan KW, Guan XY, Qin YR, et al. 2016. Role of AMPK signaling in mediating the anticancer effects of silibinin in esophageal squamous cell carcinoma. Expert Opin Ther Targets. 20:7–18.
   PubMed Web of Science ®Google Scholar
• Li YP, Pei YY, Zhang XY, Gu ZH, Zhou ZH, Yuan WF, et al. 2001. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Release. 71:203–211.
   PubMed Web of Science ®Google Scholar
• Liang Z, Yang Y, Wang H, Yi W, Yan X, Yan J, et al. 2014. Inhibition of SIRT1 signaling sensitizes the antitumor activity of silybin against human lung adenocarcinoma cells in vitro and in vivo. Mol Cancer Ther. 13:1860–1872.
   PubMed Web of Science ®Google Scholar
• Mateen S, Tyagi A, Agarwal C, Singh RP, Agarwal R. 2010. Silibinin inhibits human nonsmall cell lung cancer cell growth through cell‐cycle arrest by modulating expression and function of key cell‐cycle regulators. Mol Carcinog. 49:58–247.
   Web of Science ®Google Scholar
• Mellatyar H, Akbarzadeh A, Rahmati M, Ghalhar MG, Etemadi A, Nejati-Koshki K, et al. 2014. Comparison of inhibitory effect of 17-DMAG nanoparticles and free 17-DMAG in HSP90 gene expression in lung cancer. Asian Pac J Cancer Prev. 15:8693–8698.
   PubMed Web of Science ®Google Scholar
• Mohammadian F, Abhari A, Dariushnejad H, Nikanfar A, Pilehvar-Soltanahmadi Y, Zarghami N. 2016a. Effects of chrysin-PLGA-PEG nanoparticles on proliferation and gene expression of miRNAs in gastric cancer cell line. Iran J Cancer Prev. 9:e4190. DOI:10.17795/ijcp-4190.
   PubMed Web of Science ®Google Scholar
• Mohammadian F, Abhari A, Dariushnejad H, Zarghami F, Nikanfar A, Pilehvar-Soltanahmadi Y, et al. 2014. Upregulation of Mir-34a in AGS gastric cancer cells by a PLGA-PEG-PLGA chrysin nano formulation. Asian Pac J Cancer Prev. 16:8259–8263.
   Google Scholar
• Mohammadian F, Pilehvar-Soltanahmadi Y, Mofarrah M, Dastani-Habashi M, Zarghami N. 2016b. Down regulation of miR-18a, miR-21 and miR-221 genes in gastric cancer cell line by chrysin-loaded PLGA-PEG nanoparticles. Artif Cells Nanomed Biotechnol. 44:1972–1978.
   PubMed Web of Science ®Google Scholar
• Nejati-Koshki K, Zarghami N, Pourhassan-Moghaddam M, Rahmati-Yamchi M, Mollazade M, Nasiri M, et al. 2012. Inhibition of leptin gene expression and secretion by silibinin: possible role of estrogen receptors. Cytotechnology. 64:719–726.
   PubMed Web of Science ®Google Scholar
• Oborná J, Mravcová L, Michlovská L, Vojtová L, Vávrová M. 2016. The effect of PLGA-PEG-PLGA modification on the sol-gel transition and degradation properties. Express Polym Lett. 10:361–372.
   Web of Science ®Google Scholar
• Pooja D, Bikkina DJB, Kulhari H, Nikhila N, Chinde S, Raghavendra Y, et al. 2014. Fabrication, characterization and bioevaluation of silibinin loaded chitosan nanoparticles. Int J Biol Macromol. 69:267–273.
   PubMed Web of Science ®Google Scholar
• Shay J, Bacchetti S. 1997. A survey of telomerase activity in human cancer. Eur J Cancer. 33:787–791.
   PubMed Web of Science ®Google Scholar
• Siegel R, Naishadham D, Jemal A. 2012. Cancer statistics, 2012. CA Cancer J Clin. 62:10–29.
   PubMed Web of Science ®Google Scholar
• Singh RP, Deep G, Chittezhath M, Kaur M, Dwyer-Nield LD, Malkinson AM, et al. 2006. Effect of silibinin on the growth and progression of primary lung tumors in mice. J Natl Cancer Inst. 98:846–855.
   PubMed Web of Science ®Google Scholar
• Škottová N, ŠVagera Z, Večeřa R, Urbánek K, Jegorov A, Šimánek V. 2001. Pharmacokinetic study of iodine-labeled silibinins in rat. Pharmacol Res. 44:247–253.
   PubMed Web of Science ®Google Scholar
• Sun HP, Su JH, Meng QS, Yin Q, Zhang ZW, Yu HJ, et al. 2016. Silibinin and indocyanine green-loaded nanoparticles inhibit the growth and metastasis of mammalian breast cancer cells in vitro. Acta Pharmacologica Sinica. 37:941–949.
   PubMed Web of Science ®Google Scholar
• Surai PF 2015. Silymarin as a natural antioxidant: an overview of the current evidence and perspectives. Antioxidants (Basel). 4:204–247.
   PubMedGoogle Scholar